Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment

BACKGROUND: Sarcopenia, defined as the loss of skeletal muscle mass (MM), physical performance, and strength, has been associated with poor clinical outcomes in hepatocellular carcinoma (HCC) patients treated with several therapies. As systemic therapies, including molecular targeted agents, have a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Takahiro, Saeki, Issei, Yamauchi, Yurika, Matsumoto, Toshihiko, Suehiro, Yutaka, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Hiramatsu, Akira, Aikata, Hiroshi, Kobayashi, Kazufumi, Kondo, Takayuki, Ogasawara, Sadahisa, Chiba, Tetsuhiro, Takami, Taro, Chayama, Kazuaki, Kato, Naoya, Sakaida, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294968/
https://www.ncbi.nlm.nih.gov/pubmed/35978601
http://dx.doi.org/10.1159/000522389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294968/
https://www.ncbi.nlm.nih.gov/pubmed/35978601
http://dx.doi.org/10.1159/000522389

Ejemplares similares